0 results available. Select is focused ,type to refine list, press Down to open the menu,
I-Mab, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. It is developing givastomig, a bispecific antibody, which is in Phase 1...
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to EV / EBITDA in the valuation category include:
Measures the dollars in Enterprise Value for each dollar of EBITDA over the last twelve months.
LTM EBITDA Multiple is defined as:
EBITDA Multiple = Enterprise Value / LTM EBITDA
Applying this formula, I-Mab’s EV/EBITDA Ratio is calculated below:
Enterprise Value [ -$101.1 M ]
(/) EBITDA [ -$51.165 M ]
(=) EV/EBITDA Ratio [ 2.0x ]
The tables below summarizes the trend in I-Mab’s EV/EBITDA Ratio over the last five years:
| Date | Enterprise Value | EBITDA | EV/EBITDA Ratio |
|---|---|---|---|
| 2020-12-31 | $3.115 B | -$196.2 M | −15.9 |
| 2021-12-31 | $2.916 B | -$55.756 M | −52.3 |
| 2022-12-31 | -$222.6 M | -$267.7 M | 0.8 |
| 2023-12-31 | -$237.8 M | $30.771 M | −7.7 |
| 2024-12-31 | -$101.1 M | -$51.165 M | 2.0 |
EBITDA Multiple, Enterprise Value / EBITDA, or EV / EBITDA measures the dollars in Enterprise Value for each dollar of EBITDA.
EBITDA is used in the denominator since it is capital structure neutral and can be used to compare companies with different levels of debt (See EBITDA for benefits). We use Enterprise Value as the numerator to consider the claims on EBITDA of both debt and equity holders.
Strong revenue and EBITDA growth are highly correlated with higher EBITDA Multiples.
Read more about enterprise value (ev) and ebitda
The chart above depicts the distribution of ev / ebitda for companies operating in the Healthcare sector in the Developed economic region. Over 2,185 companies were considered in this analysis, and 2,102 had meaningful values. The average ev / ebitda of companies in the sector is 1.3x with a standard deviation of 13.9x.
I Mab's EV / EBITDA of 2.0x ranks in the 65.0% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,190 |
| Included Constituents | 2,102 |
| Min | -65.0x |
| Max | 62.4x |
| Median | -0.3x |
| Mean | 1.3x |
| Standard Deviation | 13.9x |
You can find companies with similar ev / ebitda using this stock screener.